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Abstract 
Purpose: To develop and validate a simple method using solid – phase extraction along with liquid 
chromatography–time of flight mass spectrometry for the analysis of pharmaceuticals in surface water of 
Tangkas River, Malaysia.  
Methods: Liquid chromatography (LC) was performed on a Dionex Ultimate 3000/LC 09115047 (USA) 
system equipped with a vacuum degasser, a quaternary pump, an autosampler and UV-Vis diod array 
detector. Chromatography was performed on a Thermo Scientific C18 (250 mm x 2.1 mm, i.d.: 5µm) 
column. The injection volume was 20 µL. All compounds (hydrochlorothiazide, gliclazide, diclofenac-Na 
and mefenamic acid) were analysed in negative ion (NI) mode and eluted off the column with a mobile 
phase consisting of (A) 0.1% formic acid (FA) in deionised water (DIW) and (B) 40% acetonitrile (ACN) 
in methanol (MeOH) at 0.3 ml/min. Mass spectrometry was performed on a time of flight (TOF) 
instrument. 
Results: The linearity range, 5 - 500 ng/mL, provided a determination coefficient (R2) > 0.99 for all 
compounds. The limit of detection (LOD) ranged from 65 - 136 ng/L while recovery ranged from 45 - 
111.2 % in the river water. Two pharmaceutical compounds were detected in the surface water 
samples: diclofenac sodium and mefenamic acid at concentrations of 340 and 545 ng/L, respectively. 
Conclusion: The developed method is linear in the range 5 - 500 ng/mL, and precise and acceptable 
recoveries were obtained. In addition, this method is suitable to identify and quantify trace 
concentrations of diclofenac sodium and mefenamic acid in surface water. 
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Pharmaceuticals are synthetic or natural 
chemicals that can be found in prescription 
medicines, over-the-counter therapeutic drugs 
and veterinary drugs. Pharmaceuticals contain 
active ingredients that have been designed to 
have pharmacological effects and confer 
significant benefits to society. The occurrence of 
pharmaceuticals in the environment and the 
water cycle at trace levels (in the range of 
nanograms to low micrograms per litre) has been 
widely discussed and published in the past 
decade [1-4]. Increased detection of 
pharmaceuticals in aquatic environment is largely 
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attributable to the advances in analytical 
techniques and instrumentation.  
 
Trace concentrations of pharmaceuticals in the 
water cycle have raised concerns over potential 
human health risks from exposure to very low 
levels of pharmaceuticals in drinking water. Of 
the pharmaceuticals reported in the literature, 
diclofenac and mefenamic acid (non-steroidal 
acidic anti-inflammatory drugs (NSAIDs)) are the 
most frequently mentioned as environmental 
pollutants [5-10].  
 
Determination of pharmaceuticals can be 
performed by various techniques, icluding high-
performance liquid chromatography (HPLC) [11, 
12] and gas chromatography-mass spectrometry 
(GC-MS) [13,14]. HPLC is the most common 
method used for separation and determination of 
these compounds because most 
pharmaceuticals are non-volatile. The analysis of 
drugs in a complex matrix such as surface water 
without sample preparation is very difficult. In 
general, sample preparation and concentration of 
the target analytes are often needed before 
analysis. Up to now, several procedures have 
been developed for preconcentration of 
pharmaceuticals from sample matrices including 
liquid-liquid extraction (LLE) [15] and solid-phase 
extraction (SPE) [16]. 
 
SPE offers unquestionable advantages over the 
traditional LLE technique, including greater 
extraction efficiency and lower consumption of 
organic solvents. Solid-phase microextration 
(SPME) [17], and liquid-phase micro-extraction 
[18] have been also applied for extraction of 
pharmaceuticals. Occurrence of human 
pharmaceutical pollutants in Malaysian 
environment has never been studied before 
except for Langat River [3]. This study is 
therefore aimed at investigating some 







Drug standards for hydrochlorothiazde (CAS:58-
93-5), gliclazide (CAS: 21187-98-4), diclofenac-
Na (CAS: 15307-79-6) and mefenamic acid 
(CAS: 61-68-7) were obtained from Sigma 
Aldrich (USA). Deionised water (DIW) used was 
obtained from EASYpure RODI (USA). HPLC-
grade methanol (MeOH) Merck (Germany), 
HPLC-grade acetonitrile (ACN) Merck 
(Germany), ethyl acetate J.T.Baker (USA), 
acetone (Merck, Germany) and formic acid (FA, 
Merck, Germany) were used. 
The physicochemical properties of the four 
pharmaceutical compounds analysed are shown 




LC was performed on a Dionex Ultimate 3000/LC 
09115047 (USA) system equipped with a 
vacuum degasser, a quaternary pump, an 
autosampler and UV-Vis diod array detector. 
Chromatography was performed on a Thermo 
Scientific C18 (250 mm x 2.1 mm, i.d.: 5µm) 
column. The injection volume was 20 µL. All 
compounds were analysed in negative ion (NI) 
mode and eluted off the column with a mobile 
phase consisting of (A) 0.1 % FA in DIW and (B) 
40 % ACN in MeOH at 0.3 ml/min. The elution 
started at 5% B and was then linearly increased 
to 95% B over 5 min and then kept isocratic for 5 
min. Next, the elution was returned to its starting 
conditions over 10.1 min and allowed to 
equilibrate for 5 min prior to the next run. The 
mass spectrometry was performed on a TOF 
instrument (Bruker/ Germany). The results were 
obtained with the following settings: MS capillary 
voltage, 3500; collision energy for all analytes, 2 
- 30 eV; drying – gas flow rate, 8 L/min; drying 
gas temperature, 190 0C; and nebuliser 
pressure, 4 bar. Lock mass was performed in the 
mass range m/z 100-500 using mixture of formic 
acid and sodium hydroxide. 
 
Stock and standard solutions 
 
Individual stock standard solutions (1 mg/ml) 
were prepared in HPLC-grade methanol and 
stored at ˗180C to minimise the degradation of 
the standard. A mixture of all pharmaceutical 
standards was prepared by appropriate dilution 
of the individual stock solutions. Further dilutions 
of this mixture were prepared in DIW before each 





Mixed standard solutions containing 
hydrochlorothiazide (5 - 500 ng/mL), gliclazide (5 
- 500 ng/mL), diclofenac -Na (5 - 500 ng/mL) and 
mefenamic acid (5 - 500 ng/mL) were prepared 
in methanol and further dilution with DIW. Three 
replications of 20 μL injections were made for 
each standard solution to check the repeatability 
of the detector response (peak area) at each 
concentration level. The peak area of each drug 
was plotted against the concentration to obtain a 
calibration graph. Four points of each compound 
were subjected to regression analysis to 
calculate the calibration equation and 
determination coefficients (R2). 
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Table 1: Physicochemical properties and molecular structure of pharmaceutical compounds 
 
Compound 

















318.149 4.2(RV) 0.70 100 









4.2(1) 5.12 1000( O) 




Tangkas river is one of the major rivers in 
Kajang, Malaysia. Samples of river water were 
collected in January 2013 and there was no rain 
for at least two days prior to sample collection.  
All samples were collected in 1.0 L amber glass 
bottles pre-rinsed with ultra-pure water and 
MeOH. Sampling bottles were stored at 4 0C, 
until SPE experiments, to minimize degradation 
of pollutants. 
 
Solid phase extraction (SPE) 
 
In the laboratory, 1.0 L aliquot of samples were 
filtered through 0.7 µm, GF/F filter paper from 
Whatman (UK) to remove particulate matters.  
The solid phase extraction (SPE) procedure was 
performed using Oasis HLB (3 cc) SPE 
cartridges (Waters, MA,USA).The SPE method 
was optimised using 100 mL of filtered river 
water fortified with 1 μg/L of pharmaceuticals to 
select the best elution solvent. 
 The recovery of the target analytes from 
samples was tested with the pH adjusted by 1 
mol/L HCl to pH 2.5 and without pH adjustment 
(neutral pH). For the preconcentration step, a 
GAST vacuum system (DOA-P504-BN, USA) 
was used. The cartridges were preconditioned 
with 5 mL of methanol and 5 mL of ultra-pure 
water at a flow rate 9-10 mL/min. A sample 
volume of 100 mL was percolated through the 
cartridges at a flow rate of 9 - 10 mL/min. The 
cartridges were allowed to dry for 10 min under 
vacuum to remove excess water at flow rate 14 - 
15 mL/min. The retained analytes were eluted 
with 5 mL of methanol. 
 
The extract was evaporated to dryness under a 
gentle stream of N2 gas with the aid of a hot plate 
heated at 35-40 0C and re dissolved with 1 mL of 
DIW thus, obtaining a 100 mL–fold 
preconcentration. Finally, 20 μL of the final 
concentrate was injected into LC-TOF/MS 
instrument. The injection was repeated three 
times. 
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The statistical analysis was achieved for collision 
energy, recovery and type of sorbent using 
SPSS software(Ver. 19), Analysis of Variance 





The mobile phase and elution program are 
important for achieving good separation of 
organic compounds. In this work, several 
experiments were performed using different 
elution programs and mobile phases to obtain 
the best separation and signal to noise ratio. 
Figure 1 presents the total ionic chromatogram 




Hydrochlorothiazide, gliclazide, diclofenac-Na 
and mefenamic acid showed good linearity in the 




The limit of detection (LOD) and limit of 
quantification (LOQ) were defined and 
determined as the minimum detectable amount 
of analyte with S/N ratio of 3:1 and 10:1, 
respectively, from spiked Tangkas river and 
ranged from 65 - 136 ng/L and 215 - 450 ng/L, 
respectively. 
 
The instrumental detection limits (IDLs) were 
determined by direct injection of serial dilutions of 
the standard solution as a mixture down to a 
concentration of 1.6 ng/mL. The IDL is defined as 
an S/N ratio of 3:1, and the linearity is presented 




Extraction recovery of the analytes was 
determined using deionised water (DIW) and 
Tangkas River spiked with the analytes at a 
concentration of 1 ng/mL. The reproducibility of 
the method was determined by the repeated 
analysis (n =3) of a spiked river water at 
concentrations levels of 1 ng/mL and expressed 
as the relative standard deviation (RSD) of 
replicate measurements. Three elution solvents 
were optimized to select the best solvent for 
extraction the pharmaceuticals from water as 
shown in Table 3. 
 
 
Optimisation of collision energy 
 
In order to develop an effective method for the 
analysis of the pharmaceuticals in aquatic 
environment, preliminary tests were performed in 
order to select adequate and optimum 
conditions. Collision energy was optimized at 
different values starting from 2 to 30 eV to find 
the optimum value for all analytes (Figure 2). 
 
Influence of pH adjustment on recovery 
 
The effect of sample acidification was evaluated. 
Table 4, shows the recovery obtained for 100 mL 
river water fortified with 1 ng/mL of 
pharmaceutical standards with and without pH 
adjustment using a 3 cc Oasis HLB cartridge.  
 
Effect of different cartridges 
 
Different cartridges were used to study the 
recovery of target compounds, including MCX 
(mixed mode cationic exchange), SupelcleanTM 
ENVI-Chrom P (highly crosslinked, neutral, 
specially cleaned styrene divinylbenzene co-
polymer resin used to retain hydrophobic 
compounds with some hydrophilic functionality 
under reversed phase conditions), Oasis HLB 
cartridges (universal polymeric reversed-phase 
sorbent developed for the extraction of a wide 
range of acidic, basic, and neutral compounds) 
and SupelcleanTM LC-SAX (quaternary amine, 
Cl˗ counter-ion, ion exchanger and reverse–
phase sorbent cartridge). Thus, multiple interior 
structures were used among the different 
cartridges (Table 4). 
 
Detection of pharmaceuticals in real sample 
 
Several experiments were performed to 
demonstrate the applicability of the developed 
method. The developed method was used to 
analyse surface water (Tangkas River water) in 
order to identify four pharmaceutically active 




The performance of the different elution solvents 
was evaluated, including 5 mL of  MeOH (Eluent 
1), 5 mL of ethyl acetate (Eluent 2) and a mixture 
of 3 mL of 70:30 acetone-MeOH and 2 mL of 
30:70 acetone–MeOH (Eluent 3).  All 
pharmaceuticals in this study have different 
polarities in terms of log Kow: hydrochlorothiazide 
(˗0.07), gliclazide (2.12), diclofenac-Na (0.7) and 
mefenamic acid (5.12). 
 
Based on the results obtained, 
hydrochlorothiazide is the most polar compound 
while mefenamic acid is the least polar.  
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Table 2: Instrumental performance and validation data 
 
Linearity Compound  




Hydrochlorothiazide 5-500 Y=370.081 X+9300.37 0.993 3.7 
Gliclazide 5-500 Y= 338.468 X+1287.28 0.997 3.8 
Diclofenac-Na 5-500 Y= 297.695 X+58.462 0.995 6.3 
Mefenamic acid 5-500 Y = 616.176 X + 10950.2 0.994 1.6 
 
Table 3: Optimisation of three eluents for extraction of pharmaceuticals from DIW spiked with 1 ng/Ml 
 







Hydrochlorothiazide 90.7 (0.38) 75.9 (6) 85.6 (1.2) 
Gliclazide 84.2 (0.5) 97 (6) 62 (2.8) 
Diclofenac-Na 111.8 (1.2) 116.5 (4.6) 118.6 (5.1) 
Mefenamic acid 97.9 (1.3) 111.7 (0.2) 86.4 (4.8) 
 
 
Figure 1: Total ionic chromatogram (TIC) for 
hydrochlorothiazide (Hyd); gliclazide (Glic); 






Figure 2: Optimization collision energy using LC-
ESI-QTOF/MS of mefenamic acid (□), 
hydrochlorothiazide (▲), gliclazide (●) and 
diclofenac-Na (■).  
 






Influence of pH  
(Oasis HLB) 
Recovery % 
Influence of cartridge 
Compound 
Natural, pH 6.8 pH 2.5 SAX ENV MCX 
Hydrochlorothiazide  86.9 80.4 ND 59.3 62.5 
Gliclazide 51.2 79.3 21 45.2 15 
Diclofenac-Na 111.2 39 56.2 91 55.8 
Mefenamic acid 45 23.5 28.2 49.3 42.7 
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Figure 3: TIC of pharmaceuticals in real samples and standard solution, respectively. 
 
 





Figure 5: Mass spectra (m/z) for mefenamic acid in real sample and standard solution, respectively 
 
Hydrochlorothiazide exhibited the lowest 
extraction   recovery  with  ethyl  acetate  but  the 
highest with methanol. In the case of mefenamic 
acid, the highest recovery was found with ethyl 
acetate rather than Eluent 3 or Eluent 1. These 
finding may be attributed to the polarity of the 
compounds versus the polarity strength of the 
elution solvents. Based on this result, Eluent 1 
was selected as a good compromise, since it 
extracted all the pharmaceuticals with recovery 
ranging from 84.2 - 111.8 for 100 mL of distilled 
water fortified with 1 ng/mL of pharmaceutical. 
 
Collision energy plays an important role in 
improving the S/N ratio of compounds. The 
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for all analytes. However, hydrochlorothiazide 
and mefenamic acid showed better response at 
20 eV. There was no significant difference in S/N 
ratio between 10 and 20 eV for both 
hydrochlorothiazide and mefenamic acid. Hence, 
10 eV was selected as the optimum value as it is 
a good compromise for obtaining the best 
response for all analytes.  
 
All the compounds yielded higher recoveries 
without acidification except gliclazide, in which 
there was higher recovery with acidification. This 
finding may be attributed to the protonation of (N-
H) groups in its structure at pH 2.5, thus 
gliclazide retained strongly on HLB sorbent.  
Based on the results obtained at natural pH (6.8), 
our findings agree with previous results reported 
by Gros [19].  
 
Different cartridges were used to select the base 
based on recovery values for the compounds. 
Oasis HLB exhibited better recovery for the 
compounds than the other cartridges used in this 
study. LC-SAX cartridge was only effective for 
gliclazide, diclofenac-Na and mefenamic acid. 
Hydrochlorothiazide was not extracted using LC-
SAX cartridges. Thus, this cartridge is 
recommended for the extraction of more 
hydrophobic compounds. Our results are in line 
with a previous study [19].  
 
Out of the 4 target compounds (shown in Figure 
3) only 2 compounds were detected in the river 
water sample (diclofenac-Na and mefenamic 
acid). The other target compounds may be 
absent or present at concentrations below the 
detection limits. The presence of diclofenac-Na 
and mefenamic acid has been reported in United 
Kingdom rivers but at levels that did not exceed 
160 ng/L [5]. The confirmation of the detection of 
diclofenac-Na and mefenamic acid in the surface 
water was performed by comparison to the mass 
spectra and retention times of the standards for 
each compound with error < 2 % and 5 ppm, 




The developed SPE-LC-TOF/MS method was 
precise and accurate, allowing extraction of 
hydrochlorothiazide, gliclazide, diclofenac-Na 
and mefenamic acid from water samples. The 
recovery obtained for all target compounds using 
Oasis HLB cartridge was good relative to results 
from previous studies. The developed method 
was successfully applied for the detection of two 
pharmaceutical residues, diclofenac-Na and 
mefenamic acid, in surface water (Tangkas 
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